DISOPYRAMIDE PHARMACOKINETICS DURING RECOVERY FROM MYOCARDIAL-INFARCTION

被引：13

作者：

BRYSON, SM ^{[1
]}

CAIRNS, CJ ^{[1
]}

WHITING, B ^{[1
]}

机构：

[1] STOBHILL GEN HOSP,DEPT PHARM,GLASGOW G21 3UW,SCOTLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1982年 / 13卷 / 03期

关键词：

D O I：

10.1111/j.1365-2125.1982.tb01395.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：417 / 421

页数：5

共 14 条

[1] DISOPYRAMIDE SERUM AND PHARMACOLOGIC EFFECT KINETICS APPLIED TO ASSESSMENT OF BIOAVAILABILITY
BRYSON, SM
WHITING, B
LAWRENCE, JR
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (05) : 409 - 419
[2] RAPID GAS-CHROMATOGRAPHIC DETERMINATION OF DISOPYRAMIDE IN SERUM USING A NITROGEN DETECTOR
DUCHATEAU, AMJA
MERKUS, FWHM
SCHOBBEN, F
[J]. JOURNAL OF CHROMATOGRAPHY, 1975, 109 (02): : 432 - 435
[3] ABSORPTION, HALF-LIFE, AND TOXICITY OF ORAL APRINDINE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
HAGEMEIJER, F
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 9 (01) : 21 - 25
[4] PROTEIN-BINDING AND ERYTHROCYTE PARTITIONING OF DISOPYRAMIDE AND ITS MONODEALKYLATED METABOLITE
HINDERLING, PH
BRES, J
GARRETT, ER
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (11) : 1684 - 1690
[5] PHARMACOKINETICS OF ANTIARRHYTHMIC DISOPYRAMIDE IN HEALTHY HUMANS
HINDERLING, PH
GARRETT, ER
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (03): : 199 - 230
[6] ILETT KF, 1979, CLIN PHARMACOL THER, V26, P1
[7] KARIM A, 1975, ANGIOLOGY, V26, P85
[8] PHARMACOKINETICS OF PROCAINAMIDE IN MAN
KOCHWESER, J
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) : 370 - +
[9] PHARMACOKINETICS OF DISOPYRAMIDE IN PATIENTS WITH IMMINENT TO MODERATE CARDIAC-FAILURE
LANDMARK, K
BREDESEN, JE
THAULOW, E
SIMONSEN, S
AMLIE, JP
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (03) : 187 - 192
[10] MAWER G E, 1976, Clinical Pharmacokinetics, V1, P67, DOI 10.2165/00003088-197601010-00006

← 1 2 →